SIC
FHTX icon

SJS Investment Consulting’s Foghorn Therapeutics FHTX Stock Holding History

SJS Investment Consulting’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44 Buy
+9
New +$40 ﹤0.01% 2750

Other funds holding FHTX

DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

SJS Investment Consulting's FHTX Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Foghorn Therapeutics (FHTX) in Q2 2026: 9 shares worth $44. The stake represents ﹤0.01% of the portfolio and ranks #2750 among its holdings.

7 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • SJS Investment Consulting held 9 shares of Foghorn Therapeutics worth $44 as of Q2 2026.
  • Foghorn Therapeutics was a new SJS Investment Consulting position in Q2 2026.
  • Foghorn Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2750 holding.
  • 7 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.